Report error Found 391 Enz. Inhib. hit(s) with all data for entry = 12034
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: <400nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair